L&C Bio completes ₩144.7B rights offering subscription, invests in Dongtan production base
Predicted impact: Medium· Actual: −0.7% vs sector, volume 1.6× normal (5 trading days)
Rights offering of ₩144.7B is about 9.5% of market value, but the subscription completion is a follow-up to earlier coverage.